Rusanov A. Drawing the boundaries of data disclosure in clinical trials –EMA’s perspective. Presented at DIA The Evolution of Policy 0070: EMA Clinical Data Publi cation Conference, London, 6– 7 Dec 2017.
PhUSE De-Identification Working Group. PhUSE De-identification Standard for CDISC SDTM 3.2 [Internet]. 20 May 2015 [cited 7 Mar 2018]. Available from:
Available from: https://www.phuse.eu/data-transparency
Henry-Eude AS. EMA Updates on Policy 0070 / Clinical Data Publication. Presented at DIA The Evolution of Policy 0070: EMA Clinical Data Publication Conference, London, 6–7 Dec 2017.
Heads of Medicines Agencies and European Medicines Agency. HMA/EMA guidance document on the identification of commercially confidential information and personal data within the structure of the marketing authorisation (MA) application – Release of information after the granting of a marketing authorisation. 9 Mar 2012. Available from:
Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Other/2012/03/WC500124536.pdf
Kroll, S, Holtzople, J, Adriano, A, Poulimenou, D. EMA Policy 0070 Lessons Learned. Joint Presentation between Industry and EMA. Presented at DIA The Evolution of Policy 0070: EMA Clinical Data Publication Conference, London, 6– 7 Dec 2017.